Search Results

240 results for TIVO

Why Is InVivo Therapeutics (NVIV) Stock Up 61% Today?

InVivo Therapeutics stock is rising on Tuesday with heavy trading of NVIV shares as they remain volatile after a recent bankruptcy filing.

CHX Stock: ChampionX Pops on News of Schlumberger Acquisition

ChampionX stock is taking off on Tuesday as investors in CHX shares learn of an acquisition deal with SLB set to close this year!

3 Stocks to Turn $1,000 Into $1 Million: February 2024

Why Is VivoPower (VVPR) Stock Up 260% Today?

VivoPower stock is rocketing higher on Tuesday after investors in VVPR shares learned about a SPAC merger for subsidiary Tembo.

Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement

VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news.

Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today?

Vivos Therapeutics stock is rocketing higher on Wednesday with heavy trading of VVOS shares following approval from the FDA!

Why Is Tivic Health Systems (TIVC) Stock Up 45% Today?

Tivic Health Systems (TIVC) stock is rocketing higher on Thursday after getting started on a new clinical trial and heavy trading.

Amazon Event 2021: 5 New Product Predictions That Could Be Coming Sept. 28

Amazon (AMZN) is preparing for an event where it will show off new devices in 2021 and there’s plenty of rumors about what it will…

At Green Mountain, Tech Trumps Coffee

GMCR is counting on the Keurig coffemaking machines evolving to become ever-more sophisticated. So far, that strategy is working.

TIVC Stock Earnings: Tivic Health Systems Reported Results for Q4 2023

Tivic Health Systems just reported results for the fourth quarter of 2023.

Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher

Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).

Futurescape: Betting Big on These 3 Next-Gen Tech Stocks

Amidst this ever-evolving landscape, three companies stand out as beacons of forward-thinking progress and visionary leadership.

Editas Stock Isn’t Worth Buying This Early Into Treatment Development

EDIT stock is part of a pioneering movement in CRISPR gene editing, but there’s no way to know whether the company will succeed long term.

Why Is Intellia Therapeutics (NTLA) Stock Up 10% Today?

With the FDA green lighting Intellia’s gene-editing test, NTLA stock jumped on the implications, though some concerns linger.

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential

Biotech stocks, namely those involved with gene editing, have been explosive and could see higher highs with strong catalysts.

Why Is Palisade Bio (PALI) Stock Up 57% Today?

Palisade Bio stock is up on Tuesday after the company announced positive data for its ulcerative colitis treatment PALI-2108.

3 Medical Devices Stocks to Sell Now

The overall ratings of three Medical Devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall…

4 Health Care Equipment & Supplies Stocks to Buy Now

4 Health Care Equipment & Supplies stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of…

7 Overlooked Small-Cap Stocks To Buy For Growth

Despite the huge market rally since March, there are still some great value buys among small-cap stocks, if you know where to look.

Why Is InVivo Therapeutics (NVIV) Stock Down 34% Today?

InVivo Therapeutics (NVIV) stock is on the move Friday after the company reached a deal for a direct offering of its shares.

DocuSign Layoffs 2024: What to Know About the Latest DOCU Job Cuts

DocuSign layoffs are coming for 6% of the company’s employees as it reduces its Sales & Marketing headcount in a restructuring plan.

Why Is Farfetch (FTCH) Stock Down 50% Today?

Farfetch stock is falling on Wednesday as shares of FTCH have been volatile alongside going private reports, delayed earnings and more.

Hot Stocks: The 3 Best Opportunities for Investing in Biotech 

Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

Why Is Kulr Technology (KULR) Stock Down 27% Today?

Kulr Technology (KULR) stock is falling hard on Thursday after the thermal management company announced a proposed public share offering.

9 – 10 of 240 results